Luglio Agosto 2016 - In depth review

Iron-based Phosphate Binders for ESRD Patients


Several factors influence the choice of phosphate binder for patients, including older age, male gender, post-menopause, diabetes, low bone turnover, vascular/valvular calcification and inflammation. Unlike calcium-based phosphate binders, non-calcium-based phosphate binders, such as sevelamer and lanthanum carbonate, have been able to reduce the progression of bone disease to adynamic bone among patients with CKD.

New iron-based phosphate binders are now available. With multiple options available for the reduction of phosphate, the focus has been on agents that do not contain calcium. This is because it is thought that calcium itself functions as a substrate for calcification.

Key words: dialysis, hyperphosphatemia, iron-based phosphate binders, secondary hyperparathyroidism

Full text of the article is available in Italian.